Correlation of genomic and expression alterations of AS3 with esophageal squamous cell carcinoma

Androgen-induced proliferation shutoff gene AS3, also known as APRIN, is a growth inhibitory gene that is initially implicated in prostate cancer. This gene is required for androgen-dependent growth arrest and is a primary target for 1,25(OH)2D3 and androgens. Allelic loss at AS3 locus has been link...

Full description

Saved in:
Bibliographic Details
Published inJournal of genetics and genomics Vol. 35; no. 5; pp. 267 - 271
Main Author Yu Zhang Xiaoping Huang Jun Qi Cai Yan Xin Xu Yaling Han Mingrong Wang
Format Journal Article
LanguageChinese
Published 2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Androgen-induced proliferation shutoff gene AS3, also known as APRIN, is a growth inhibitory gene that is initially implicated in prostate cancer. This gene is required for androgen-dependent growth arrest and is a primary target for 1,25(OH)2D3 and androgens. Allelic loss at AS3 locus has been linked to a variety of cancers. However, the correlation of genomic and expression alterations of AS3 with esophageal squamous cell carcinoma (ESCC) is not well established. In this study, the genornic and expression alterations of AS3 in ESCC and their clinical significance are evaluated. Loss of heterozygosity (LOH) analysis using an AS3 intragenic microsatellite marker D13S171 revealed 72% allelic loss at AS3 locus in ESCC, which is significantly correlated with higher pathological grade (P=0.042). RT-PCR examination showed that AS3 mRNA obviously decreased in 44% tumors and its down-regulation was correlated with the sex of patients (P=0.03). Furthermore, the correlation between genornic and expression alterations
Bibliography:esophageal squamous cell carcinoma
esophageal squamous cell carcinoma; AS3/APRIN; loss of heterozygosity; down-regulation; hormone
AS3/APRIN
down-regulation
11-5450/R
loss of heterozygosity
hormone
R73
ISSN:1673-8527